Published in J Infect Dis on December 14, 2001
Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol (2008) 1.30
HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest (2007) 1.22
Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer (2008) 1.18
Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses (2012) 1.12
Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Fam Cancer (2006) 1.08
The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis. PLoS One (2011) 0.99
Molecular epidemiology of gastric cancer: current status and future prospects. Gastrointest Cancer Res (2007) 0.96
A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk. DNA Cell Biol (2012) 0.93
The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer (2006) 0.92
Interleukin-10 genotype correlated to deficiency syndrome in hepatitis B cirrhosis. Evid Based Complement Alternat Med (2012) 0.87
The -1082A>G polymorphism in promoter region of interleukin-10 and risk of digestive cancer: a meta-analysis. Sci Rep (2014) 0.86
Functional promoter -308G>A variant in tumor necrosis factor α gene is associated with risk and progression of gastric cancer in a Chinese population. PLoS One (2013) 0.85
Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog (2003) 0.85
Host genetics of Epstein-Barr virus infection, latency and disease. Rev Med Virol (2014) 0.84
Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis. World J Gastroenterol (2011) 0.84
TNF-α-308 polymorphism and risk of digestive system cancers: a meta-analysis. World J Gastroenterol (2013) 0.84
Interleukin10 -592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci (2009) 0.82
Role for HLA in susceptibility to infectious mononucleosis. J Clin Invest (2007) 0.80
Helicobacter pylori infection and gastric carcinoma: Not all the strains and patients are alike. World J Gastrointest Oncol (2016) 0.79
Population differences concerning TNF-α gene polymorphisms in gastric carcinogenesis based on meta-analysis. Ann Gastroenterol (2014) 0.79
TNF-α-308G/A polymorphisms and nasopharyngeal cancer risk: a meta-analysis. Eur Arch Otorhinolaryngol (2012) 0.78
Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. Br J Cancer (2009) 0.78
Null genotypes of glutathione S-transferase μ1 and glutathione S-transferase θ1 are associated with osteosarcoma risk: A meta-analysis. Oncol Lett (2015) 0.78
Interleukin-10 promoter polymorphism and susceptibility to lung cancer: a systematic review and meta-analysis. Int J Clin Exp Med (2015) 0.77
Morphometric analysis of the balance between CXCR3+ T cells and FOXP3+ regulatory T cells in lymphocyte-rich and conventional gastric cancers. Virchows Arch (2010) 0.77
Association of IL10 -819C>T and -592C>A Polymorphisms with Non-Hodgkin Lymphoma Susceptibility: Evidence from Published Studies. J Cancer (2015) 0.76
Association of interleukin-10 promoter polymorphisms and corresponding plasma levels with susceptibility to laryngeal squamous cell carcinoma. Oncol Lett (2014) 0.75
Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients. Mem Inst Oswaldo Cruz (2014) 0.75
Association between angiotensinogen T174M polymorphism and ischemic stroke: A meta-analysis. J Res Med Sci (2015) 0.75
Association of interleukin-10-1082 promoter polymorphism with gastric cancer: appraisal of a recent meta-analysis. DNA Cell Biol (2012) 0.75
The relationship between tumor necrosis factor-α polymorphisms and gastric cancer risk: An updated meta-analysis. Biomed Rep (2017) 0.75
Association of three promoter polymorphisms in interleukin-10 gene with cancer susceptibility in the Chinese population: a meta-analysis. Oncotarget (2017) 0.75
Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection. JAMA (2012) 6.80
A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med (2004) 4.81
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet (2012) 4.62
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut (2012) 3.56
Tracheal rapid ultrasound exam (T.R.U.E.) for confirming endotracheal tube placement during emergency intubation. Resuscitation (2011) 3.34
Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. Lancet Oncol (2013) 2.58
Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults. Surg Endosc (2012) 2.28
Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol (2004) 2.26
Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatology (2013) 2.20
A prospective comparative study of narrow-band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of colorectal neoplasia. Gut (2006) 2.14
Clinical manifestations and management of buried bumper syndrome in patients with percutaneous endoscopic gastrostomy. Gastrointest Endosc (2008) 2.08
Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol (2008) 2.08
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut (2012) 2.05
The impact of colon preparation timing on colonoscopic detection of colorectal neoplasms--a prospective endoscopist-blinded randomized trial. Am J Gastroenterol (2006) 2.03
Isolation of multipotent cells from human term placenta. Stem Cells (2005) 2.03
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood (2012) 2.03
Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology (2009) 2.02
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy. J Clin Oncol (2008) 1.93
Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res (2003) 1.89
Randomized trial of 1-minute versus 5-minute endoscopic balloon dilation for extraction of bile duct stones. Gastrointest Endosc (2010) 1.83
Intraobserver and interobserver consistency for grading esophagitis with narrow-band imaging. Gastrointest Endosc (2007) 1.83
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.82
Modified hospital elder life program: effects on abdominal surgery patients. J Am Coll Surg (2011) 1.79
Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test. Clin Gastroenterol Hepatol (2013) 1.75
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: a multicenter phase II study. Oncology (2013) 1.70
Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas (2011) 1.64
Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J Infect Dis (2005) 1.63
Spontaneous urinary extravasation: an overlooked cause of acute abdomen in ED. Am J Emerg Med (2006) 1.61
The effectiveness of silver-releasing dressings in the management of non-healing chronic wounds: a meta-analysis. J Clin Nurs (2009) 1.59
Endoscopic submucosal dissection for gastric epithelial tumors: a multicenter study in Taiwan. J Formos Med Assoc (2009) 1.59
Male gender and renal dysfunction are predictors of adverse outcome in nonpostoperative ischemic colitis patients. J Clin Gastroenterol (2010) 1.55
The antioxidant protein alkylhydroperoxide reductase of Helicobacter pylori switches from a peroxide reductase to a molecular chaperone function. Proc Natl Acad Sci U S A (2006) 1.54
Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis. Eur J Gastroenterol Hepatol (2010) 1.52
Esophageal obstruction by a tangled nasogastric tube. Gastrointest Endosc (2010) 1.49
MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Res (2010) 1.49
Long-term follow-up of ulcerative colitis in Taiwan. J Chin Med Assoc (2012) 1.48
DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys. J Clin Invest (2016) 1.47
Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy (2010) 1.47
Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J Biomed Sci (2004) 1.47
Myocardial ischemia during endoscopic retrograde cholangiopancreatography: an overlooked issue with significant clinical impact. J Gastroenterol Hepatol (2010) 1.46
Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer (2003) 1.45
Long-term outcome of patients with acute cholecystitis receiving antibiotic treatment: a retrospective cohort study. World J Surg (2014) 1.45
Male gender is a risk factor for recurrent appendicitis following nonoperative treatment. World J Surg (2011) 1.43
Diagnosing porcelain gallbladder. Am J Med (2005) 1.41
Percutaneous transgastric traction-assisted esophageal endoscopic submucosal dissection: a randomized controlled trial in a porcine model. Scand J Gastroenterol (2012) 1.41
Fas/Fas ligand pathway is involved in the resolution of type II pneumocyte hyperplasia after acute lung injury: evidence from a rat model. Crit Care Med (2002) 1.41
Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am J Pathol (2010) 1.40
Colonic abscess. Gastrointest Endosc (2004) 1.39
miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest (2011) 1.38
Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene (2004) 1.38
Selective use of ultrasonography for the detection of pneumoperitoneum. Acad Emerg Med (2002) 1.36
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst (2005) 1.35
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival. Gut (2006) 1.35
Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res (2010) 1.34
Gastric Cancer Working Group report. Jpn J Clin Oncol (2010) 1.31
Transcatheter arterial embolization of acute upper gastrointestinal tract bleeding with N-butyl-2-cyanoacrylate. J Vasc Interv Radiol (2007) 1.30
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology (2014) 1.27
Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol (2010) 1.23
Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol (2005) 1.23
T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin Chem (2007) 1.21
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial. J Antimicrob Chemother (2012) 1.20
Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer. Head Neck (2011) 1.18
Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res (2008) 1.18
Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem (2002) 1.18
Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.18
Mesenteric lipoblastoma: case report. Pediatr Radiol (2002) 1.17
Functional polymorphisms of CD14 and toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies. Hepatogastroenterology (2006) 1.17
Appendiceal outer diameter as an indicator for differentiating appendiceal mucocele from appendicitis. Am J Emerg Med (2006) 1.15